These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19946143)

  • 1. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes.
    Goldacre B
    BMJ; 2009 Nov; 339():b4949. PubMed ID: 19946143
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? No.
    Lawton V
    BMJ; 2009 Nov; 339():b4953. PubMed ID: 19946144
    [No Abstract]   [Full Text] [Related]  

  • 3. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethical issues in the relationships involving medicine and industry.
    Thomas PS; Tan KS; Yates DH
    Intern Med J; 2005 Dec; 35(12):732. PubMed ID: 16313554
    [No Abstract]   [Full Text] [Related]  

  • 5. Research dishonesty and conflict of interest.
    Frizelle F
    N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
    [No Abstract]   [Full Text] [Related]  

  • 6. Industry sponsored research.
    Klotz LH
    Can J Urol; 2004 Aug; 11(4):2312-3. PubMed ID: 15380051
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug firm conflicting interests. Radical change, not tweaking, is needed.
    Noble JH
    BMJ; 2009 Dec; 339():b5656. PubMed ID: 20044405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Independent clinical trials are imperative].
    Gøtzsche PC
    Ugeskr Laeger; 2005 Apr; 167(14):1491-4. PubMed ID: 15887740
    [No Abstract]   [Full Text] [Related]  

  • 9. In the dark: drug companies should be forced to publish all the results of clinical trials.
    Chalmers I
    New Sci; 2004 Mar 6-12; 181(2437):19. PubMed ID: 15139350
    [No Abstract]   [Full Text] [Related]  

  • 10. Small study on industry trial sponsorship leads to big questions about quality and bias.
    Twombly R
    J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials.
    Roehr B
    BMJ; 2012 May; 344():e3767. PubMed ID: 22641830
    [No Abstract]   [Full Text] [Related]  

  • 12. [Something for something--physicians, drug industry and general welfare].
    Bro F; Olesen F
    Ugeskr Laeger; 2006 Nov; 168(46):3985. PubMed ID: 17125648
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
    Newcombe JP; Kerridge IH
    Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 15. The potential for bias in reporting of industry-sponsored clinical trials.
    Pyke S; Julious SA; Day S; O'Kelly M; Todd S; Matcham J; Seldrup J
    Pharm Stat; 2011; 10(1):74-9. PubMed ID: 21275037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pens and other pharmaceutical industry gifts.
    Brody H
    Am J Bioeth; 2003; 3(3):58-60. PubMed ID: 14594497
    [No Abstract]   [Full Text] [Related]  

  • 17. Correspondence (letter to the editor): Trend gives cause for concern.
    Maier C; Zenz M
    Dtsch Arztebl Int; 2010 Sep; 107(38):670-1; author reply 673-4. PubMed ID: 20953257
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating solutions to sponsorship bias.
    Doucet M; Sismondo S
    J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
    Campbell MJ
    Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.